Wafaa A. Elatre

Wafaa A. Elatre, MD, PhD, is a Clinical Associate Professor of Pathology at the University of Southern California. Her work bridges clinical pathology with molecular oncology, focusing on diagnostic challenges in cancer subtyping, biomarker discovery, and translational research. Her research spans carcinoid tumors, breast and ovarian cancers, lung stem cell biology, and idiopathic pulmonary fibrosis. She has contributed to advancements in fine needle aspiration techniques, gene expression profiling for ovarian carcinoma subtypes, and the role of PTEN and HER2 in breast cancer prognosis.

Dr. Elatre's publications reflect a commitment to precision medicine, including studies on Claudin-18-mediated YAP signaling in lung tumorigenesis and FDG PET/CT imaging of prostate cancer metastases. Her early work in cardiovascular pharmacology explored nesiritide's impact on heart failure outcomes. Despite no explicit mention of awards, her prolific publication record underscores her academic contributions.

As a clinician educator, she integrates patient care with training in diagnostic pathology and molecular diagnostics. No formal advising roles or student lists are provided, but her collaborative research projects suggest involvement in academic teams. Her work is published in high-impact journals like Clin Cancer Res, Am J Respir Crit Care Med, and J Clin Invest.